Research Article 
Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease
Kevin C. Maki, Michael H. Davidson, Mary R. Dicklin, Marjorie Bell, MarySue Witchger and Steven B. Feinstein
Journal of Clinical Lipidology, 2011, 5(3), 141-151. DOI: 10.1016/j.jacl.2011.02.003
Abstract
Background
The rate of carotid intima media thickness (CIMT) progression has been widely used in clinical trials as a surrogate marker for subclinical atherosclerosis.
Objective
The aim of this study was to investigate relationships between coronary heart disease (CHD) risk markers and progression of CIMT in patients at moderate CHD risk.
Methods
Participants included men (45-75 years) and women (55-74 years) in the control arm of a clinical trial. All had at least one major CHD risk factor and baseline posterior wall CIMT 0.7-2.0 mm, without significant stenosis. Posterior (n = 134) and anterior wall (in a subset, n = 72) CIMT were assessed with B-mode ultrasound at baseline and 12 and ∼18 months. Fasting lipoprotein lipid, apolipoprotein (Apo), inflammatory, and oxidative stress markers were evaluated.
Results
Baseline CIMT was inversely associated (P < .001) with CIMT progression. After adjustment for baseline CIMT, significant predictors of anterior wall CIMT progression in linear regression analyses included glucose (P = .044), high-density lipoprotein cholesterol (HDL-C, inverse, P = .006), triglycerides (TG, P = .006), and ratios of total cholesterol (TC)/HDL-C (P = .013), TG/HDL-C (P = .005), and Apo B/HDL-C (P = .021). Posterior wall CIMT progressed on average, whereas anterior wall CIMT regressed (0.0078 vs −0.0164 mm/year, P = .014). Significant baseline CIMT-adjusted predictors of posterior wall CIMT progression included TC (P = .028), low-density lipoprotein-C (P = .035), non-HDL-C (P = .004), TG (P = .016), Apo B (P = .005), and ratios of TC/HDL-C (P < .001), TG/HDL-C (P = .015), Apo B/Apo AI (P = .012) and Apo B/HDL-C (P = .004).
Conclusion
The strongest predictors for CIMT progression in anterior and posterior walls were lower baseline CIMT, increased TG, and elevated ratios, including TC/HDL-C, TG/HDL-C and Apo B/HDL-C.
ASCI-ID: 2746-198
Similar Articles
High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosis
Journal of Clinical Lipidology, 2008, 2(1), 4-11. DOI: 10.1016/j.jacl.2007.11.002
Coronary heart disease risk factors and atherosclerosis in young peopleJournal of Clinical Lipidology, 2008, 2(3), 118-126. DOI: 10.1016/j.jacl.2008.02.006
Getting the word out: Teaching middle-school children about cardiovascular diseaseJournal of Clinical Lipidology, 2008, 2(3), 179-188. DOI: 10.1016/j.jacl.2008.03.004
Flushing and the HDL-C response to extended-release niacinJournal of Clinical Lipidology, 2008, 2(4), 285-288. DOI: 10.1016/j.jacl.2008.05.002
Medical management of patients before the incidence of a cardiovascular eventJournal of Clinical Lipidology, 2009, 3(5), 315-321. DOI: 10.1016/j.jacl.2009.08.002
Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering-lipoprotein changes and interactions: the SANDS studyJournal of Clinical Lipidology, 2009, 3(5), 322-331. DOI: 10.1016/j.jacl.2009.09.001
High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal womenJournal of Clinical Lipidology, 2009, 3(5), 345-350. DOI: 10.1016/j.jacl.2009.08.003
Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoringJournal of Clinical Lipidology, 2009, 3(6), 385-392. DOI: 10.1016/j.jacl.2009.10.004
High-density lipoproteins: Marker of cardiovascular risk and therapeutic targetJournal of Clinical Lipidology, 2010, 4(5), 359-364. DOI: 10.1016/j.jacl.2010.08.002
Functions of cholesterol ester transfer protein and relationship to coronary artery disease riskJournal of Clinical Lipidology, 2010, 4(5), 389-393. DOI: 10.1016/j.jacl.2010.08.006
Update on CETP inhibitionJournal of Clinical Lipidology, 2010, 4(5), 394-398. DOI: 10.1016/j.jacl.2010.08.003
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?Journal of Clinical Lipidology, 2010, 4(5), 399-404. DOI: 10.1016/j.jacl.2010.08.018
Associations among smoking status, lifestyle and lipoprotein subclassesJournal of Clinical Lipidology, 2010, 4(6), 522-530. DOI: 10.1016/j.jacl.2010.09.003
Carotid intima-media thickness for the practicing lipidologistJournal of Clinical Lipidology, 2010, 4(1), 24-35. DOI: 10.1016/j.jacl.2009.11.004
Impact of lipid profile and high blood pressure on endothelial damageJournal of Clinical Lipidology, 2011, 5(6), 460-466. DOI: 10.1016/j.jacl.2011.06.005
Effect of Aggressive Cardiovascular Risk Factor Treatment on Progression of Carotid Intima-Media Thickness: Experience of an Atherosclerosis CenterJournal of Clinical Lipidology, 2012, 6(3), 262-263. DOI: 10.1016/j.jacl.2012.04.027
Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglycerideJournal of Clinical Lipidology, 2012, 6(5), 462-468. DOI: 10.1016/j.jacl.2012.02.004
Relationships between alcohol intake and atherogenic indices in womenJournal of Clinical Lipidology, 2013, 7(5), 454-462. DOI: 10.1016/j.jacl.2013.03.009
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemiaJournal of Clinical Lipidology, 2013, 7(6), 561-565. DOI: 10.1016/j.jacl.2013.10.001
A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapyJournal of Clinical Lipidology, 2014, 8(2), 223-230. DOI: 10.1016/j.jacl.2013.11.005
Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: A case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS)Journal of Clinical Lipidology, 2014, 8(5), 489-493. DOI: 10.1016/j.jacl.2014.07.004
Lipids and lipoprotein ratios: Contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitusJournal of Clinical Lipidology, 2013, 7(5), 441-445. DOI: 10.1016/j.jacl.2013.05.002
Lipid-altering effects of different formulations of hydroxypropylmethylcelluloseJournal of Clinical Lipidology, 2009, 3(3), 159-166. DOI: 10.1016/j.jacl.2009.04.053
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: The Stop Atherosclerosis in Native Diabetics Study (SANDS)Journal of Clinical Lipidology, 2010, 4(3), 165-172. DOI: 10.1016/j.jacl.2010.01.008
Attainment of low-density lipoprotein cholesterol goals in coronary artery diseaseJournal of Clinical Lipidology, 2010, 4(3), 173-180. DOI: 10.1016/j.jacl.2010.03.002
Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatmentJournal of Clinical Lipidology, 2008, 2(4), 248-266. DOI: 10.1016/j.jacl.2008.06.003
Plasma lipids in Nigerians with systemic arterial hypertensionJournal of Clinical Lipidology, 2008, 2(4), 274-278. DOI: 10.1016/j.jacl.2008.03.002
Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular eventsJournal of Clinical Lipidology, 2008, 2(5), 343-353. DOI: 10.1016/j.jacl.2008.06.009
Increasing lipid adherence to goalJournal of Clinical Lipidology, 2008, 2(5), 354-359. DOI: 10.1016/j.jacl.2008.06.010
Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analysesJournal of Clinical Lipidology, 2008, 2(2), 91-105. DOI: 10.1016/j.jacl.2008.02.002
Plasma coenzyme Q10 predicts lipid-lowering response to high-dose atorvastatinJournal of Clinical Lipidology, 2008, 2(4), 289-297. DOI: 10.1016/j.jacl.2008.05.001
Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG Study A5152sJournal of Clinical Lipidology, 2008, 2(6), 464-471. DOI: 10.1016/j.jacl.2008.08.442
Lipoprotein particle profiles by nuclear magnetic resonance spectroscopy in medically underserved HIV-infected personsJournal of Clinical Lipidology, 2009, 3(6), 379-384. DOI: 10.1016/j.jacl.2009.10.005
Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoringJournal of Clinical Lipidology, 2009, 3(6), 385-392. DOI: 10.1016/j.jacl.2009.10.004
Is directly measured low-density lipoprotein clinically equivalent to calculated low-density lipoprotein?Journal of Clinical Lipidology, 2010, 4(4), 259-264. DOI: 10.1016/j.jacl.2010.05.003
Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patientsJournal of Clinical Lipidology, 2010, 4(4), 272-278. DOI: 10.1016/j.jacl.2010.05.002
Achieving lipid targets in adults with type 2 diabetes: The Stop Atherosclerosis in Native Diabetics StudyJournal of Clinical Lipidology, 2010, 4(5), 435-443. DOI: 10.1016/j.jacl.2010.07.007
The effects of adherence and persistence on clinical outcomes in patients treated with statins: A systematic reviewJournal of Clinical Lipidology, 2010, 4(6), 462-471. DOI: 10.1016/j.jacl.2010.08.026
Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006Journal of Clinical Lipidology, 2010, 4(6), 483-490. DOI: 10.1016/j.jacl.2010.10.002
Differences in lipoprotein particle subclass distribution for Japanese Americans in Hawaii and Japanese in Japan: The INTERLIPID StudyJournal of Clinical Lipidology, 2011, 5(1), 30-36. DOI: 10.1016/j.jacl.2010.11.007
Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: Do novel lipid parameters offer an advantage?Journal of Clinical Lipidology, 2011, 5(2), 82-90. DOI: 10.1016/j.jacl.2010.12.001
Carotid intima-media thickness for the practicing lipidologistJournal of Clinical Lipidology, 2010, 4(1), 24-35. DOI: 10.1016/j.jacl.2009.11.004
An evaluation of alanine transaminase and creatine kinase elevations with the use of ezetimibe in an ambulatory care settingJournal of Clinical Lipidology, 2010, 4(6), 501-507. DOI: 10.1016/j.jacl.2010.08.024
The association of apolipoprotein E polymorphism and lipid levels in children with a family history of premature coronary artery diseaseJournal of Clinical Lipidology, 2012, 6(1), 81-87. DOI: 10.1016/j.jacl.2011.06.017
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolismJournal of Clinical Lipidology, 2012, 6(2), 132-138. DOI: 10.1016/j.jacl.2011.09.005
Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemiaJournal of Clinical Lipidology, 2012, 6(3), 235-243. DOI: 10.1016/j.jacl.2011.11.004
Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006Journal of Clinical Lipidology, 2012, 6(4), 325-330. DOI: 10.1016/j.jacl.2012.05.002
A meta-analysis of randomized controlled trials that compare the lipid effects of beef versus poultry and/or fish consumptionJournal of Clinical Lipidology, 2012, 6(4), 352-361. DOI: 10.1016/j.jacl.2012.01.001
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical settingJournal of Clinical Lipidology, 2013, 7(2), 102-108. DOI: 10.1016/j.jacl.2012.06.006
Lipids and lipoprotein ratios: Contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitusJournal of Clinical Lipidology, 2013, 7(5), 441-445. DOI: 10.1016/j.jacl.2013.05.002
Pregnancy during adolescence has lasting adverse effects on blood lipids: A 10-year longitudinal study of black and white femalesJournal of Clinical Lipidology, 2012, 6(2), 139-149. DOI: 10.1016/j.jacl.2011.12.004
Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemiaJournal of Clinical Lipidology, 2012, 6(5), 443-449. DOI: 10.1016/j.jacl.2012.03.002
Correlation between serum lipids and 1-hour postload plasma glucose levels in normoglycemic individualsJournal of Clinical Lipidology, 2014, 8(2), 217-222. DOI: 10.1016/j.jacl.2013.12.003
Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adultsJournal of Clinical Lipidology, 2014, 8(5), 501-509. DOI: 10.1016/j.jacl.2014.06.005